Chevalier RL - Search Results

1

Congenital Anomalies of the Kidney and Urinary Tract: A Continuum of Care.

Lange-Sperandio B, Anders HJ, Stehr M, Chevalier RL, Klaus R. Lange-Sperandio B, et al. Among authors: chevalier rl. Semin Nephrol. 2023 Oct 27:151433. doi: 10.1016/j.semnephrol.2023.151433. Online ahead of print. Semin Nephrol. 2023. PMID: 39492016 Review.

2

CAKUT: A Pediatric and Evolutionary Perspective on the Leading Cause of CKD in Childhood.

Chevalier RL. Chevalier RL. Pediatr Rep. 2023 Feb 10;15(1):143-153. doi: 10.3390/pediatric15010012. Pediatr Rep. 2023. PMID: 36810342 Free PMC article. Review.

3

The first randomized controlled trial in pediatric nephrology: the history of the International Study of Kidney Disease in Children (ISKDC).

Primack WA, Chevalier RL, Friedman A, Lemley KV, Norwood VF, Schwartz GJ, Silverstein D, Kaskel F. Primack WA, et al. Among authors: chevalier rl. Pediatr Nephrol. 2023 Dec;38(12):3947-3954. doi: 10.1007/s00467-022-05838-1. Epub 2023 Jan 10. Pediatr Nephrol. 2023. PMID: 36625931 Clinical Trial.

4

Bioenergetics: the evolutionary basis of progressive kidney disease.

Chevalier RL. Chevalier RL. Physiol Rev. 2023 Oct 1;103(4):2451-2506. doi: 10.1152/physrev.00029.2022. Epub 2023 Mar 30. Physiol Rev. 2023. PMID: 36996412 Free article. Review.

5

Why is chronic kidney disease progressive? Evolutionary adaptations and maladaptations.

Chevalier RL. Chevalier RL. Am J Physiol Renal Physiol. 2023 Nov 1;325(5):F595-F617. doi: 10.1152/ajprenal.00134.2023. Epub 2023 Sep 7. Am J Physiol Renal Physiol. 2023. PMID: 37675460 Free article. Review.

6

Identification of Plasma Metabolomic Biomarkers of Juvenile Idiopathic Arthritis.

Kumar A, Tatarian J, Shakhnovich V, Chevalier RL, Sudman M, Lovell DJ, Thompson SD, Becker ML, Funk RS. Kumar A, et al. Among authors: chevalier rl. Metabolites. 2024 Sep 16;14(9):499. doi: 10.3390/metabo14090499. Metabolites. 2024. PMID: 39330506 Free PMC article.

7

Evolution-informed therapy for kidney disease.

Chevalier RL. Chevalier RL. Evol Med Public Health. 2023 Aug 28;11(1):316-317. doi: 10.1093/emph/eoad027. eCollection 2023. Evol Med Public Health. 2023. PMID: 37711226 Free PMC article. No abstract available.

8

Impact of early life development on later onset chronic kidney disease and hypertension and the role of evolutionary trade-offs.

Luyckx VA, Chevalier RL. Luyckx VA, et al. Among authors: chevalier rl. Exp Physiol. 2022 May;107(5):410-414. doi: 10.1113/EP089918. Epub 2022 Jan 17. Exp Physiol. 2022. PMID: 35037332 Free PMC article. Review.

9

Glomerulopathy.

Boaz NT, Chevalier RL. Boaz NT, et al. Among authors: chevalier rl. Evol Med Public Health. 2021 May 25;9(1):220. doi: 10.1093/emph/eoab015. eCollection 2021. Evol Med Public Health. 2021. PMID: 34285808 Free PMC article. No abstract available.

10

Bioenergetic Evolution Explains Prevalence of Low Nephron Number at Birth: Risk Factor for CKD.

Chevalier RL. Chevalier RL. Kidney360. 2020 Jul 7;1(8):863-879. doi: 10.34067/KID.0002012020. eCollection 2020 Aug 27. Kidney360. 2020. PMID: 35372951 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

203 results

Search Page

Filters